Search - tctmd.com

Displaying 1 - 20 of 442

Sort: Relevancy | Date

Presentation Miami Valves 2025

Clinical Trials Propel TAVR Forward

Presenter: Jeffrey Popma

January 30, 2025

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

TAVR of Yesterday is not the TAVR of the Future

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation Interventional Complications 2022

TAVR and Unexplained Hypotension: An Algorithmic Approach

Presenter: Frederick Welt

July 15, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2020

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Presenter: Rebecca T. Hahn

October 17, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

Presentation

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

January 08, 2020

Presentation

Navigating Optimal Implantation Depth (ID) With Self-Expandable TAVR Device in Daily Clinical Practice

December 19, 2019

Presentation Controversies and Advances 2019

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Presenter: Raj R. Makkar

November 15, 2019

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

Presenter: Ariana Gonzálvez-García

September 29, 2019

Presentation

RAS Inhibition Following TAVR

July 29, 2019

Presentation TVT 2019

The LOTUS Edge TAVR System: Clinical Trial Updates

Presenter: Chris Meduri

June 13, 2019

Advertisement

Clinical Trials Propel TAVR Forward

The EARLY TAVR Trial Editorial Commentary

Continuation versus Interruption of Oral Anticoagulation during TAVI

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

New Cerebral Protection Devices for TAVR

Valve Function Insights from Bench Testing

TAVR of Yesterday is not the TAVR fo the Future

TAVR and Unexplained Hypotension: An Algorithmic Approach

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

Navigating Optimal Implantation Depth (ID) With Self-Expandable TAVR Device in Daily Clinical Practice

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Show me the Data: Key Clinical Trials of 2019

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

RAS Inhibition Following TAVR

The LOTUS Edge TAVR System: Clinical Trial Updates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content